OpenAlex
PricingAboutJobs
Log inGet started
Work

Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations

HTML

Year: 2014
Type: review
Source: American Society of Clinical Oncology Educational Book
DOI: 10.14694/edbook_am.2014.34.e353
Authors: David E. Gerber, Leena Gandhi, Daniel B. Costa
Institutions: Beth Israel Deaconess Medical Center, Harvard University, Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: non-small cell lung cancer, actionable driver mutations, tyrosine kinase inhibitors, EGFR mutation, ALK rearrangement, crizotinib, gefitinib, erlotinib, afatinib, KRAS, ROS1, RET, BRAF, NTRK1, fibroblast growth factor receptor, precision oncology, predictive biomarkers, progression-free survival
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: G2081079141
OpenAlex ID: W2045465355
FWCI: 2.358
Cites: 90
Cited by: 93
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security